Repeated doses of pantoprazole have no influence on the pharmacokinetic profile of eplivanserin, a new sleep agent, in healthy male subjects

被引：0
|
作者：
Krupka, E. [1 ]
Saubadu, S. [2 ]
Ollier, C. [3 ]
Brunet, A. [3 ]
机构：
[1] Montpellier Ctr, Montpellier, France
[2] Sanofi Aventis, Chilly Mazarin, France
[3] Sanofi Aventis, Montpellier, France
来源：
SLEEP | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
121
引用
收藏
页码：A39 / A39
页数：1
相关论文
共 50 条
  • [21] The effect of multiple doses of ramelteon (TAK-375) on the singledose pharmacokinetic profile of midazolam in healthy adult subjects
    Karim, A
    Tolbert, D
    Cao, C
    Zhao, Z
    Sainati, SM
    SLEEP, 2004, 27 : 47 - 48
  • [22] The safety, tolerability and pharmacokinetic profile of multiple doses of AD 452, a new once daily small molecule, broad spectrum anti-cytokine DMARD, in healthy male subjects.
    Mercer, A. J.
    Baker, H.
    Eltringham, E.
    Febbraro, S.
    Bakhtyari, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S36 - S36
  • [23] Effect of repeated doses of darunavir plus low-dose ritonavir on the pharmacokinetics of sildenafil in healthy male subjects
    Sekar, V.
    Lefebvre, E.
    De Marez, T.
    De Pauw, M.
    De Paepe, E.
    Vangeneugden, T.
    Hoetelmans, R. M. W.
    CLINICAL DRUG INVESTIGATION, 2008, 28 (08) : 479 - 485
  • [24] Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Multiple-Doses of DRL-17822, a Potent Cholesteryl Ester Transfer Protein Inhibitor in Healthy Male Subjects
    Dasari, Mallikarjuna Rao
    Bapat, Abhijit
    Vittal, Shivva
    Tippana, Mangapathiraju
    Hasham, Sumera
    Sai, Sesha M.
    Alikunju, Shanavas
    Sadashivam, Vasu
    Allenby, Kent
    Kumar, Rajinder
    CIRCULATION, 2010, 122 (21)
  • [25] Safety, Tolerability and Pharmacokinetic Profile of Single and Multiple Oral Doses of Arterolane ( RBx11160) Maleate in Healthy Subjects
    Saha, Nilanjan
    Moehrle, Joerg J.
    Zutshi, Anita
    Sharma, Pradeep
    Kaur, Pawandeep
    Iyer, Sunil S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (04): : 386 - 393
  • [26] Food consumption has no effect on the pharmacokinetic parameters of a single oral 5-mg dose of eplivanserin, a novel sleep compound. after administration to healthy subjects
    Nougarede, R.
    Brunet, A.
    Clot, P.
    JOURNAL OF SLEEP RESEARCH, 2008, 17 : 211 - 211
  • [27] Safety, tolerability and pharmacokinetic profile of Fibrillex™ (anti-AA amyloid agent) in healthy and renal impaired subjects
    Garceau, D
    Gurbindo, C
    Laurin, J
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 39 - 39
  • [28] THE PHARMACOKINETICS OF CROMAKALIM, BRL 34915, A NEW ANTIHYPERTENSIVE AGENT, IN HEALTHY MALE-SUBJECTS
    DAVIES, BE
    DIERDORF, D
    ECKL, KM
    GREB, WH
    MELLOWS, G
    THOMSEN, T
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (01) : P136 - P137
  • [29] Pharmacokinetic profile of the long-acting GLP-1 derivative NN2211 in healthy male subjects
    Jakobsen, G
    Agerso, H
    Elbroend, B
    Jensen, LB
    DIABETES, 2001, 50 : A118 - A118
  • [30] Pharmacokinetic, Pharmacodynamic, and Safety Profile of a New Cholesteryl Ester Transfer Protein Inhibitor in Healthy Human Subjects
    Wolk, R.
    Chen, D.
    Clark, R. W.
    Mancuso, J.
    Barclay, P. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 430 - 437
12345